Healius Health Care
Healthcare Medical

$3.18 0.09 (2.91%)

High $3.18	Low $3.12	Trades 1,177	Turnover $3,954,133	Volume 1,248,327
30 June 2023 at 4:12pm

Market Cap (25-Sep) $273,769,408 (160th)	Close (30-Jun) $3.18 0 (0%)	Volume (30-Jun) 1,248,327	Shortsold (21-Sep) 36,401,155 (5.01%) (64th)
52w High $1.07	52w Low $0.300	P/E 29.24	EPS -0.56

Short Interest

ASIC data, 21 Sep 2026

% Shorted

5.01% 0.83

vs 5.85% prior report

Most Shorted Rank

64th

of 696 shorted ASX stocks

Peak Short

10.81%

Jun 2026

Days to Cover

6.9

at 50d avg vol

View full short position history →

	Subject
	HLS HLS Article: Labor threatens pathology giants with price fixing probe over fee hike
	1 (current) 2 3
	HLS HLS Article: Affinity PE closes $515m Lumus Imaging debt deal
	HLS HLS Article: Affinity Equity Partners last man standing in Healius’ Lumus auction
	HLS HLS Article: ASX falls; Brambles, Charter Hall soar
	HLS HLS Article: ASX falls; Charter Hall, Breville surge
	HLS HLS Article: Healius net losses double as it restructures, sells imaging unit
	HLS HLS Article: ASX to slip, Perpetual names new CEO, lower LNG prices hit Santos
	HLS HLS Article: Key bidder departs Healius’ $700m Lumus Imaging auction
	HLS HLS Article: PE titans lob bids for Healius’ $700m Lumus Imaging; UBS offers staple
	HLS HLS Article: Radiology’s AI future and deregulation help end years of bad blood
	HLS HLS Article: Healius to sell $650m X-ray and ultrasound division after UBS review
	HLS HLS Article: Why Rio Tinto is worth more than its $130 price tag
	HLS HLS Article: Healius in management shake-up after CEO exit
	HLS HLS Article: Making excuses for weak margins has ended: Healius CEO
	HLS HLS Article: Making excuses for weak margins has ended: Healius CEO
	HLS HLS Article: Making excuses for weak margins has ended: Healius CEO
	HLS HLS Article: Healius brings in UBS as it reviews strategy, considers asset sales
	HLS HLS Article: How a little acquisition exposed Healius’ core and has heads rolling
	HLS HLS Article: Healius CEO exits as strategic review speeds up
	HLS HLS Article: Healius flags asset sales and plans to shut some operations
	HLS HLS Article: ASX retreats, Coles jumps, defying profit drop
	HLS HLS Article: ASX edges lower; Oil spikes, Healius drops
	HLS HLS Article: John Wylie’s share fund draws new commitments, avenging down year
	HLS HLS Article: ACL pulls Healius bid as ACCC blocks pathology shake-up
	HLS HLS Article: Why it’s so hard to make money from blood tests
	HLS HLS Article: Healius chair exits without apology for $2b wipeout
	HLS HLS Article: Healius slammed over withheld patient data
	HLS HLS Article: Heads on sticks shows investors out of patience
	HLS HLS Article: Healius equity issue highlights need for long-term domestic debt
	HLS HLS Article: BGH Capital ready to bare its fangs at Healius over 2020 deal
	HLS HLS Article: Pezzullo sacked; Healius boss exits; Is Goldman wrong?
	HLS HLS Article: Healius chairwoman exits as ‘no’ vote looms
	HLS HLS Article: Miners drag ASX lower; QBE, Healius shares rally
	HLS HLS Article: ACL accuses Wylie of hiding links to independent Healius director
	HLS HLS Article: Healius boss says company’s economics have been upended as wages rise
	HLS HLS Article: Wylie’s Tanarra circulates Healius attack letter as shares slide
	HLS HLS Article: The Barclays Wimbledon box puts Healius in a spin
	HLS HLS Article: Banks sign off on healthcare group Healius’ long fall from grace
	HLS HLS Article: Dividend drought adds to pain for Healius shareholders
	HLS HLS Article: Terms out for Healius’ $187m rights issue
	HLS HLS Article: ASX rallies, buoyed by Regal Partners ahead of Fed meeting
	HLS HLS Article: ASX lifts, building approvals tumble 4.6pc; BHP bullish on potash
	HLS HLS Article: Struggling Healius backs former PE suitor’s bid for board seat
	HLS HLS Article: Lazard’s Hofflin is sticking with Healius despite ‘disappointment’
	HLS HLS Article: PEP, QIC run health check at Cura Day Hospitals; indicative bids land
	HLS HLS Article: Kerry Stokes trims Boral stake; Healius, City Chic kills dividend
	HLS HLS Article: ACCC inches closer to blocking $2b Healius-ACL merger proposal
	HLS HLS Article: Pathology dream deal a three-headed competition nightmare
	HLS HLS Ann: Notification regarding unquoted securities - HLS
	HLS HLS Article: Why Nathan Parkin is betting big on small caps

Similar Companies

Apiam Animal Health

AHX

BARD1 Life Sciences

BD1

Capitol Health

CAJ

Healthia

HLA

Integral Diagnostics

IDX

Rhythm Biosciences

RHY

Sonic Healthcare

SHL

SILK Laser Australia Ltd

SLA

Total Brain

TTB

End of Day Prices

Date	Close	Volume	Change
25-Sep	$0.38	13,723,863	+0.02 (5.56%)
24-Sep	$0.36	0	0.00 (0.00%)
23-Sep	$0.36	10,737,531	-0.01 (1.37%)
22-Sep	$0.37	11,252,058	-0.01 (2.67%)
21-Sep	$0.38	9,660,469	-0.01 (1.32%)
18-Sep	$0.38	57,441,660	-0.07 (14.61%)
17-Sep	$0.45	808,455	0.00 (0.00%)
16-Sep	$0.45	1,780,233	-0.01 (2.20%)
15-Sep	$0.46	6,850,017	+0.03 (7.06%)
14-Sep	$0.43	5,815,302	-0.01 (1.16%)
11-Sep	$0.43	3,722,045	0.00 (0.00%)
10-Sep	$0.43	4,401,442	-0.01 (2.27%)
09-Sep	$0.44	1,587,036	-0.03 (5.38%)
08-Sep	$0.47	3,351,804	+0.01 (1.09%)
07-Sep	$0.46	2,584,610	+0.01 (1.10%)
4 up, 8 down, and 3 flat days

Healius Health Care
Healthcare Medical

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

HLS Healius Health Care Healthcare Medical

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

Healius Health Care
Healthcare Medical